A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a phase II clinical trial.

TWO women lose their lives to cervical cancer every day in the UK. Like all types of the disease, the earlier it’s caught, the better. Around 95 per cent of those diagnosed at stage 1 will ...

An investigational therapeutic vaccine showed clinical effectiveness in patients with human papillomavirus (HPV)16-positive ...

A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical ...

A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a phase II clinical trial published ...

When symptoms do occur, they may include unusual vaginal bleeding (after intercourse, between periods, or post-menopause), ...

HPV can cause a variety of cancers, including cervical. New mortality data for women under 25 point to the success of the HPV vaccine.

Cervical cancer is a significant health issue in India, caused primarily by the human papilloma virus (HPV). Screening ...

Of note, many patients remained in the cohort and were untested through this first round of surveillance (overall: 49.4%; ...

Currently, one woman dies every two minutes from this disease, which is caused by the human papillomavirus (HPV).

The connection between oral sex and cancer has become a topic of growing concern in recent years. This relationship centers ...